AbbVievsOmada Health

ABBV and OMDA stock compared: price, dividend, valuation and results, from SEC filings.

AbbVie (ABBV) has a market value of $522B and Omada Health (OMDA) $889M. Over the last year, with dividends, ABBV moved +30.3% and OMDA -33.2%. The P/E is 50.7 for ABBV and 63.4 for OMDA. Dividend yield: ABBV 2.35%, OMDA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$522B

    OMDA$889M

    ABBV is 587 times OMDA

  • Revenue, 12 months

    ABBV$66.0B

    OMDA$333M

    ABBV is 198 times OMDA

  • Net income, 12 months

    ABBV$10.3B

    OMDA$14M

    ABBV is 737 times OMDA

  • Operating margin

    ABBV32.2%

    OMDA2.1%

    30.1 points apart

  • ROIC

    ABBV25.7%

    OMDA2.3%

    23.4 points apart

  • P/E

    ABBV50.7

    OMDA63.4

    OMDA is 1.3 times ABBV

  • Dividend yield

    ABBV2.4%

    OMDA0.0%

    2.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+30.3%

OMDA-33.2%

5075100125DecFebAprJunAugOct
Returns by period
PeriodABBVWith dividendsOMDAWith dividends
1 year since November 12, 2025+30.3%Price +26.5%-33.2%Price -33.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieOMDAOmada Health

Valuation

ABBVOMDA
Valuation
Price$295.03$14.33
Market value$522B$889M
Enterprise value (EV)$592B$646M
P/E50.763.4
P/E, 5-year median57.0–
P/B–3.3
EV/EBIT27.994.0
Free cash flow yield3.6%3.2%

Results and growth

ABBVOMDA
Results and growth
Revenue, 12 months$66.0B$333M
Net income, 12 months$10.3B$14M
Free cash flow, 12 months$18.9B$28M
Earnings per share, 12 months$5.81$0.23
Revenue growth, year on year8.6%53.2%
Revenue growth a year, past+5.9%over 5 years+45.6%over 2 years
EPS growth a year, past-2.8%over 5 years–

Margins and returns on capital

ABBVOMDA
Margins and returns on capital
Gross margin73.7%70.7%
Operating margin32.2%2.1%
Net margin15.7%4.2%
ROIC25.7%2.3%
ROE–5.8%

Balance sheet

ABBVOMDA
Balance sheet
Cash$10.8B$243M
Total debt$80.9B$0
Net debt / EBITDA3.2-19.7
Interest cover7.1×22.4×

Dividends and buybacks

ABBVOMDA
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%–
Shareholder yield2.5%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or OMDA

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Omada Health?

By market value, AbbVie ($522B) is about 586.8 times Omada Health ($889M), at today's prices.

How did ABBV and OMDA stock do over the last 1 years?

Since November 12, 2025, ABBV's price moved +26.5% and OMDA's -33.2%. With dividends: ABBV +30.3% (+30.3% a year), OMDA -33.2% (-33.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or OMDA?

The dividend yield at today's price is 2.35% for AbbVie and none for Omada Health. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and OMDA?

At today's price, the P/E is 50.7 for ABBV and 63.4 for OMDA. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, AbbVie or Omada Health?

Over the last twelve months, the net margin was 15.7% for AbbVie and 4.2% for Omada Health, and the operating margin 32.2% and 2.1%. Revenue was $66.0B and $333M.

Which is the better investment, AbbVie or Omada Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.